Phaos Technology Holdings (Cayman) Limited
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in mate… Read more
Phaos Technology Holdings (Cayman) Limited (POAS) - Net Assets
Latest net assets as of July 2025: $-1.96 Million USD
Based on the latest financial reports, Phaos Technology Holdings (Cayman) Limited (POAS) has net assets worth $-1.96 Million USD as of July 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.93 Million) and total liabilities ($3.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.96 Million |
| % of Total Assets | -101.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Phaos Technology Holdings (Cayman) Limited - Net Assets Trend (2023–2025)
This chart illustrates how Phaos Technology Holdings (Cayman) Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Phaos Technology Holdings (Cayman) Limited (2023–2025)
The table below shows the annual net assets of Phaos Technology Holdings (Cayman) Limited from 2023 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $-1.96 Million | -167.21% |
| 2024-04-30 | $2.92 Million | +196.79% |
| 2023-04-30 | $-3.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Phaos Technology Holdings (Cayman) Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 749690800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.51K | % |
| Other Comprehensive Income | $-1.14K | % |
| Other Components | $10.20 Million | % |
| Total Equity | $-1.96 Million | 100.00% |
Phaos Technology Holdings (Cayman) Limited Competitors by Market Cap
The table below lists competitors of Phaos Technology Holdings (Cayman) Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Premium Textile Mills Ltd
KAR:PRET
|
$15.19K |
|
CBEE3F
SA:CBEE3F
|
$15.19K |
|
Camellia Plc
LSE:CAM
|
$15.19K |
|
Astika Holdings
PINK:ASKH
|
$15.21K |
|
NXDR
NYSE:NXDR
|
$15.17K |
|
SH INDUSTRIAL (SGI.SG)
STU:SGI
|
$15.17K |
|
EROS INTL
BE:E1O
|
$15.17K |
|
Team Internet Group PLC
LSE:TIG
|
$15.16K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Phaos Technology Holdings (Cayman) Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,920,204 to -1,962,808, a change of -4,883,012 (-167.2%).
- Net loss of 5,137,064 reduced equity.
- Share repurchases of 337,330 reduced equity.
- New share issuances of 255,195 increased equity.
- Other comprehensive income decreased equity by 1,143.
- Other factors increased equity by 337,330.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.14 Million | -261.72% |
| Share Repurchases | $337.33K | -17.19% |
| Share Issuances | $255.19K | +13.0% |
| Other Comprehensive Income | $-1.14K | -0.06% |
| Other Changes | $337.33K | +17.19% |
| Total Change | $- | -167.21% |
Book Value vs Market Value Analysis
This analysis compares Phaos Technology Holdings (Cayman) Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-04-30 | $-0.23 | $1.56 | x |
| 2024-04-30 | $0.22 | $1.56 | x |
| 2025-04-30 | $-0.15 | $1.56 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Phaos Technology Holdings (Cayman) Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3063.12%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-26.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | 0.00% | -256.27% | 0.47x | 0.00x | $-1.37 Million |
| 2024 | -80.81% | -125.34% | 0.36x | 1.78x | $-2.65 Million |
| 2025 | 0.00% | -3063.12% | 0.09x | 0.00x | $-4.94 Million |
Industry Comparison
This section compares Phaos Technology Holdings (Cayman) Limited's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Phaos Technology Holdings (Cayman) Limited (POAS) | $-1.96 Million | 0.00% | N/A | $15.19K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |